NGEN

NERVGEN PHARMA CORP. NGEN

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

No SEC XBRL data

This company has no XBRL financial filings on file with SEC EDGAR. Common for ADRs, recent IPOs, OTC-listed names, and foreign filers that haven't filed 20-F yet.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$25.04M total
Empery Asset Management, LP
$8.24MNew
Rock Springs Capital Management LP
$2.49MNew
DAFNA Capital Management LLC
$2.16MNew
Ghisallo Capital Management LLC
$2.06MNew
ARMISTICE CAPITAL, LLC
$1.40MNew
LMR Partners LLP
$1.24MNew
MARSHALL WACE, LLP
$898.1K+117.6%
UBS Group AG
$782.2K+517.3%
Stonepine Capital Management, LLC
$740.2KNew
JANE STREET GROUP, LLC
$557.7KNew
Woodline Partners LP
$516.0KNew
PFG Investments, LLC
$448.1K+8.2%
BANK OF AMERICA CORP /DE/
$383.6K-7.2%
ROYAL BANK OF CANADA
$363.0K+2.4%
BANK OF MONTREAL /CAN/
$284.4K+24.6%
Quadrature Capital Ltd
$277.1KNew
Integrated Wealth Concepts LLC
$152.9K-14.5%
CAPTRUST FINANCIAL ADVISORS
$132.7K+3.3%
GEODE CAPITAL MANAGEMENT, LLC
$119.6KNew
OSAIC HOLDINGS, INC.
$105.3K+27.8%
HRT FINANCIAL LP
$90.0K+105.3%
AXQ CAPITAL, LP
$88.8KNew
LIBERTY WEALTH MANAGEMENT LLC
$82.9K0.0%
MILLENNIUM MANAGEMENT LLC
$81.9KNew
GREAT VALLEY ADVISOR GROUP, INC.
$73.1K+69.0%
See all 62 institutional holders →
Reading the latest SEC filing…

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Loading ratio trend…

About NERVGEN PHARMA CORP. (NGEN): stock profile, AI score and financials

NERVGEN PHARMA CORP. (NGEN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NGEN is not currently included in 13F Pro's AI-ranked quality universe — this company has no xbrl financial filings on file with sec edgar. common for adrs, recent ipos, otc-listed names, and foreign filers that haven't filed 20-f yet. Top institutional holders of NGEN by reported 13-F value include Empery Asset Management, Rock Springs Capital Management, DAFNA Capital Management, based on the most recent SEC filings. NGEN trades on the Nasdaq exchange and files with the SEC under CIK 1751912. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NGEN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NERVGEN PHARMA CORP. directly from SEC EDGAR.

SEC EDGAR: CIK 1751912 →